Sign up to save your podcasts
Or
Share A Stem Cell-Derived Treatment for T1D
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
A Stem Cell-Derived Treatment for T1D
We love to hear from our listeners. Send us a message.
Sernova Corp. is a clinical-stage regenerative therapies company currently focused on insulin-dependent diabetes. CEO and President, Philip Toleikis, Ph.D., details the company's on-going clinical trial to treat Type 1 diabetes (T1D) as well as the very real potential to progress from simply masking symptoms to having a functional cure for T1D. Toleikis also provides his take on the near-term future of regenerative medicine.
Subscribe to the podcast!
Apple | Spotify | YouTube
Visit my website: Cell & Gene
Connect with me on LinkedIn
View all episodes
By Erin Harris
4.9
3838 ratings
We love to hear from our listeners. Send us a message.
Sernova Corp. is a clinical-stage regenerative therapies company currently focused on insulin-dependent diabetes. CEO and President, Philip Toleikis, Ph.D., details the company's on-going clinical trial to treat Type 1 diabetes (T1D) as well as the very real potential to progress from simply masking symptoms to having a functional cure for T1D. Toleikis also provides his take on the near-term future of regenerative medicine.
Subscribe to the podcast!
Apple | Spotify | YouTube
Visit my website: Cell & Gene
Connect with me on LinkedIn
More shows like Cell & Gene: The Podcast
View all
Fareed Zakaria GPS
3,465 Listeners
Nature Podcast
754 Listeners
HBR IdeaCast
153 Listeners
Science Magazine Podcast
819 Listeners
The Daily
113,483 Listeners
Today, Explained
10,342 Listeners
The Readout Loud
336 Listeners
Short Wave
6,581 Listeners
The Prof G Pod with Scott Galloway
5,662 Listeners
Consider This from NPR
6,445 Listeners
Business Of Biotech
87 Listeners
Hard Fork
5,596 Listeners
The Weekly Show with Jon Stewart
10,976 Listeners
ASGCT Podcast Network
16 Listeners
Prof G Markets
1,477 Listeners